The Patent Finder

Faulk Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Faulk Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 9 of 9 · Back to Faulk Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,420,665Anti-Cancer Compounds
Formerly held
Lapsed on the fee record
Ended Apr 16, 2025 · High confidence
Lapsed on the fee recordEnded Apr 16, 2025High confidence
US 8,183,208Targeted delivery of drugs for the treatment of viral infections
Formerly held
Term ended
Term ended Dec 29, 2022 · USPTO record
Term endedTerm ended Dec 29, 2022USPTO record
US 7,101,842Targeted delivery of drugs for the treatment of parasitic infections
Formerly held
Term ended
Term ended Oct 29, 2022 · USPTO record
Term endedTerm ended Oct 29, 2022USPTO record
US 7,001,991Targeted delivery of bioaffecting compounds for the treatment of cancer
Formerly held
Term ended
Ended no later than May 15, 2022 · USPTO record
Term endedEnded no later than May 15, 2022USPTO record
US 7,417,023Targeted delivery of bioaffecting compounds for the treatment of cancer
Formerly held
Term ended
Term ended May 15, 2022 · USPTO record
Term endedTerm ended May 15, 2022USPTO record
US 4,886,780Conjugates of apotransferrin proteins with anti-tumor agents
Formerly held
Term ended
Term ended no later than Dec 12, 2009 · Low confidence
Term endedTerm ended no later than Dec 12, 2009Low confidence
US 4,895,714Radioiodinated apotransferrin for use in tumor diagnosis, imaging, localization or treatment
Formerly held
Term ended
Term ended no later than Jan 23, 2010 · Low confidence
Term endedTerm ended no later than Jan 23, 2010Low confidence
US 5,000,935Treatment method utilizing transferrin-radioiodine conjugate
Formerly held
Term ended
Term ended no later than Mar 19, 2011 · Low confidence
Term endedTerm ended no later than Mar 19, 2011Low confidence
US 5,108,987Conjugates of proteins with anti-tumor agents
Formerly held
Term ended
Term ended no later than Apr 28, 2012 · Low confidence
Term endedTerm ended no later than Apr 28, 2012Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited